Irinotecan Hydrochloride

NDC 60505-6272 · Apotex Corp.

Generic nameIrinotecan Hydrochloride

Dosage formINJECTION, SOLUTION

RouteINTRAVENOUS

Active ingredient(s)IRINOTECAN HYDROCHLORIDE

Strength20 mg/mL

Pharmacologic classTopoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]

Marketing categoryANDA

Packages

60505-6272-1 — 1 VIAL, SINGLE-USE in 1 CARTON (60505-6272-1) / 5 mL in 1 VIAL, SINGLE-USE

Billed under HCPCS

J9206 — Injection, irinotecan, 20 mg Medicare Part B payment limit (ASP + 6%): $1.85

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

16714-131 — Irinotecan hydrochloride, 25021-230 — irinotecan hydrochloride, 45963-614 — Irinotecan hydrochloride, 50742-401 — Irinotecan Hydrochloride, 50742-402 — Irinotecan Hydrochloride, 55150-352 — IRINOTECAN HYDROCHLORIDE, 55150-353 — IRINOTECAN HYDROCHLORIDE, 55150-354 — IRINOTECAN HYDROCHLORIDE, 55150-355 — IRINOTECAN HYDROCHLORIDE, 60505-6128 — Irinotecan Hydrochloride, 61703-349 — Irinotecan Hydrochloride, 63323-193 — IRINOTECAN HYDROCHLORIDE, 67184-0511 — Irinotecan Hydrochloride, 67184-0512 — Irinotecan Hydrochloride, 67184-0513 — Irinotecan Hydrochloride, 68001-480 — Irinotecan hydrochloide, 68083-381 — Irinotecan hydrochloide, 68083-382 — Irinotecan hydrochloride, 70700-169 — Irinotecan hydrochloide, 70700-170 — Irinotecan hydrochloride, +8 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.